Loading formats...
Zealand Stock Craters
Description
Zealand Pharma shares plunged after trial data showed high dropout and vomiting rates for its experimental weight-loss drug survodutide.
Discover more
More from this user
00:53
Gold Breaks Out
Benzinga
00:48
Strategy Backs Trump Accounts
Benzinga
00:47
Disney+ Explores Free Tier
Benzinga
00:56
WBD Streaming Jumps
Benzinga
00:53
Grocery Costs Squeeze
Benzinga
00:55
Disney Parks Hit Record
Benzinga
Related videos
08:27
Weight loss drug debate: Experts urge strict guidelines for GLP-1 drugs
India Today
02:41
Megyn Kelly Blasts Oprah Winfrey for Calling Obesity a 'Disease' as She Promotes GLP-1 Drugs During Book Tour: 'Cop Out'
Straight Arrow News
00:38
'Stop Ripping Us Off.' Senate Grills Novo Nordisk on High Prices of Weight Loss Drugs Wegovy and Ozempic in US.
Benzinga
01:26
Cut-rate GLP-1 weight-loss drugs
New York Post
00:48
Novo Nordisk Shares Jump After CEO Predicts Wegovy Recovery as Compounded Drugs Exit U.S. Market
Benzinga
00:35
Ro's Supply Tracker Helps Patients Locate In-Demand GLP-1 Drugs Amid Shortages
Benzinga